Now that Man of Steel has proven to be a success, fans are wondering if Time Warner's (NYSE: TWX ) next step will be to pair its two biggest superheroes in a big-screen team-up, says Fool contributor Tim Beyers in the following video.
Fans' interest in a Batman-Superman film comes at an interesting time. Next week, Warner and DC Entertainment will be at San Diego Comic-Con to talk more about its big-screen plans, which presumably include a Justice League film by 2015.
Would such an accelerated schedule make sense? And if not, would a Batman-Superman film make more sense? Tim isn't sure, if only because the logistics of pulling off such an audacious project while also filming Man of Steel 2 might be too much for Warner to do well.
Therein lies the danger, Tim says. The last time Warner tried to do too much on screen, the result was a box office bomb called Green Lantern. And yet Warner may not have the necessary time to mimic Walt Disney's (NYSE: DIS ) measured approach, which means betting on big names, and beloved characters may its best hope for boosting profits.
Top Low Price Companies To Invest In Right Now: Etfs Gold Trust (SGOL)
ETFS Gold Trust (the Trust) is an investment trust. The investment objective of the Trust is for the Shares to reflect the performance of the price of gold bullion, less the expenses of the Trust�� operations. The Trust holds gold bullion and issues ETFS Physical Swiss Gold Shares (the Shares) in exchange for deposits of gold and distributes gold in connection with redemption of Baskets. The sponsor of the Trust is ETF Securities USA LLC (the Sponsor). The trustee of the Trust is The Bank of New York Mellon and the custodian is JP Morgan Chase Bank N.A. Advisors' Opinion:- [By Peter Pham]
Although the Fed doubled its bond buying last September, the top gold exchange-traded funds, or ETFs, including SPDR Gold Shares (NYSEMKT: GLD ) , iShares Gold Trust (NYSEMKT: IAU ) , and ETFS Physical Swiss Gold Shares (NYSEMKT: SGOL ) , have dropped around 25% each over the last 12 months, which speaks to gold's extreme vulnerability to QE tapering. Even the mere mention of tapering seems to send gold into a tailspin, as seen with SPDR Gold Shares, which has plunged 24% year to date and also suffered massive losses with its physical holdings. Market Vectors Gold Miners ETF (NYSEMKT: GDX ) has suffered a massive drop of 48% so far in 2013, making it one of the worst-performing ETFs this year.
5 Best Logistics Stocks To Watch Right Now: Allergan Inc. (AGN)
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the La p-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Keith Speights]
First, the good news. ACADIA stated on Monday that its partner Allergan (NYSE: AGN ) advanced another new chemical entity from the two companies' collaboration into pre-clinical development. ACADIA's CEO, Dr.��Uli Hacksell, said the molecule has "distinctly different properties from other glaucoma compounds" previously advanced by Allergan. The two companies first partnered on development of new treatments for glaucoma back in 2003.
- [By Wallace Witkowski]
Plus, more than 120 companies on the S&P 500 report next week with notable releases from Apple Inc. (AAPL) and Biogen Idec Inc. (BIIB) �on Monday; Gilead Sciences Inc. (GILD) �and Allergan Inc. (AGN) �on Tuesday; Starbucks Corp. (SBUX) �, General Motors Co. (GM) , and Comcast Corp. (CMCSA) �on Wednesday; along with MasterCard Inc. (MA) �and ConocoPhillips (COP) �on Thursday.
- [By Ben Levisohn]
This morning, Allergan (AGN) finally had its answer for Valeant (VRX), which is seeking to acquire it in partnership with Pershing Square. The answer was no.
BloombergAllergan said that it didn’t believe Valeant’s strategy of big spending cuts–which Allergan’s CEO dubbed “cutting and slashing”– would produce long-term value for shareholders, and said Allergan could grow at a 20% to 25% clip on its own.
Citigroup’s Liav Abraham wonders if this is all Allergan has to fend off Valeant:
Notwithstanding the value proposition of AGN on a stand-alone basis, we wonder whether today�� revised targets are sufficient to convince AGN shareholders against a VRX/AGN combination given investors��investment horizons. We anticipate that the AGN Board is considering additional strategic alternatives for the company, including more aggressive deployment of AGN�� robust balance sheet and/or seeking a ��hite knight��bid.
Aegis Capital Corp.’s Raghuram Selvaraju notes that the news isn’t good for Valeant, but he doesn’t think Allergan will have much luck finding a savior:
Nevertheless, while we believe that the rejection vote is a setback to Valeant, we remain confident that Valeant will either ultimately succeed in its bid to acquire Allergan near-term or seek to consummate another transaction elsewhere. We note that thus far it does not appear that Allergan has much strategic wiggle room, having already been rebuffed by potential white knights such as Sanofi S.A. (SNY) and Johnson & Johnson (JNJ) and with little chance, in our view, of making a meaningful acquisition of its own, such as the purchase of Shire (SHPG).
Sterne Agee’s Shibani Malhotra thinks most Allergan shareholders will support Allergan over Valeant:
Most investors we have spoken to agree that there are business risks to Valeant�� acquisition of Allergan and that, over the long
5 Best Logistics Stocks To Watch Right Now: Metro Bancorp Inc(METR)
Metro Bancorp, Inc. operates as the bank holding company for Metro Bank, which provides a range of retail and commercial banking services to consumers and small and mid-sized companies in Pennsylvania. Its deposit products include personal and business checking accounts, regular savings accounts, money market accounts, interest checking accounts, fixed rate certificates of deposit, individual retirement accounts, and club accounts. The company?s loan products portfolio comprises commercial and industrial, owner occupied real estate, commercial construction and land development, and commercial real estate loans; consumer loans, including home equity, overdraft checking protection, and consumer credit cards, as well as installment loans for home improvement, and the purchase of consumer goods and automobiles; and construction loans and permanent mortgages for homes. It also offers debit card services, online banking services, safe deposit facilities, and automated teller fa cilities. As of July 14, 2011, Metro Bancorp operated 33 stores in the counties of Berks, Cumberland, Dauphin, Lancaster, Lebanon, and York. The company was formerly known as Pennsylvania Commerce Bancorp, Inc. and changed its name to Metro Bancorp, Inc. in June 2009. Metro Bancorp, Inc. was founded in 1984 and is headquartered in Harrisburg, Pennsylvania.
Advisors' Opinion:- [By Tim Melvin]
Metro Bancorp (METR) is one bank that might consider selling based on these metric. The company�� return on assets has consistently been well below its peer group, and the equity-to-asset ratio is just 8.46 — well below the 11 average across the United States.
5 Best Logistics Stocks To Watch Right Now: Renewable Energy Group Inc (REGI)
Renewable Energy Group, Inc., incorporated in August 2006, is a producer of biodiesel in the United States. The Company is engaged in each aspect of biodiesel production, from acquiring feedstock, managing construction and operating biodiesel production facilities to marketing, selling and distributing biodiesel and its co-products. During the year ended December 31, 2011, the Company sold approximately 150 million gallons of biodiesel. As of December 31, 2011, the Company operated a network of six biodiesel plants, with an aggregate production capacity of 212 million gallons per year. On July 12, 2011, the Company acquired SoyMor Biodiesel, LLC (SoyMor), which has 30 million gallons per year biodiesel production facility in Albert Lea, Minnesota. In January 2012, it exercised its option to purchase the 60 million gallons per year facility in Seneca, Illinois, which it operated under a lease. In August 2013, the Company acquired biodiesel plant in Mason City, Iowa. In January 2014, Renewable Energy Group Inc acquired renewable chemical technology developer LS9, Inc.
The Company produces its biodiesel from a range of feedstocks, including inedible animal fat, used cooking oil and inedible corn oil. It also produces a smaller portion of its biodiesel from virgin vegetable oils. It owns biodiesel production facilities with capacities consisting of 12 million gallons per year facility in Ralston, Iowa; 35 million gallons per year facility near Houston, Texas, or the Houston facility; 45 million gallons per year facility in Danville, Illinois, and 30 million gallons per year facility in Newton, Iowa.
The Company competes with Archer Daniels Midland Company, Cargill, Incorporated, Louis Dreyfus Commodities Group, Ag Processing Inc., Mansfield, Astra, Gavilon, Tenaska, ED&F Man, Dynamic Fuels, LLC, Syntroleum Corporation, Tyson Foods, Inc., Diamond Green Diesel, LLC and Darling International.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of biodiesel maker Renewable Energy Group (NASDAQ: REGI ) jumped 15% today after the company reported earnings.
So what: The company sold 39 million gallons of biodiesel during the quarter, up 14% from a year ago, and net income rose from $14 million, to $46 million. On a per share basis earnings were $1.25 versus an expectation of $0.51 from Wall Street.�
- [By John Udovich] Syntroleum Corp. A producer of synthetic fuels from a wide variety of feedstock, from natural gas to fats, oils and greases, Syntroleum Corp uses the�Fischer-Tropsch process to produce significant amounts of synthetic diesel and jet fuel as well as its Bio-Synfining庐�technology to produce renewable synthetic fuels with the same superior qualities. Back in December, it was announced that Renewable Energy Group Inc (NASDAQ: REGI) would acquire substantially all of the assets of Syntroleum Corp with the terms of the transaction calling for SYNM to receive 3,796,000 shares of REG common stock (subject to reduction in the event that the aggregate market value of the REG common stock to be issued would exceed $49 million or if the cash transferred to REG is less than $3.2 million). The CEO of the Renewable Energy Group commented:
��ombining Syntroleum�� renewable and synthetic fuel technologies with REG�� expertise in biodiesel production, sales, marketing and logistics should be a positive outcome for investors in both companies. This will help us grow our advanced biofuel business, enhance our intellectual property portfolio, expand our geographic footprint and launch REG into new customer segments.��/p>
No comments:
Post a Comment